theory clinical_3_2
imports Main

begin

typedecl entity
typedecl event

consts
  LossOfBRCA2 :: "entity ⇒ bool"
  ChromosomeBreakage :: "entity ⇒ bool"
  Cause :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  InhibitionOfPARP :: "entity ⇒ bool"
  CollapsedReplicationForks :: "entity ⇒ bool"
  DoubleStrandBreaks :: "entity ⇒ bool"
  Result :: "event ⇒ bool"
  PARPInhibitors :: "entity ⇒ bool"
  Directly :: "event ⇒ bool"
  CancerDevelopment :: "entity ⇒ bool"
  Drive :: "event ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  GenomicInstability :: "entity"
  TrappingOfPARP1 :: "entity ⇒ bool"
  Increase :: "event ⇒ bool"
  NonHomologousEndJoining :: "entity"
  Toxicity :: "entity"
  SingleStrandBreakRepair :: "entity ⇒ bool"
  Prevent :: "event ⇒ bool"
  Lead :: "event ⇒ bool"
  ReplicationAssociatedDoubleStrandBreaks :: "entity"
  Rely :: "event ⇒ bool"
  On :: "event ⇒ entity ⇒ bool"
  DefectiveHomologousRecombinationRepair :: "entity"
  ErrorProneNonHomologousEndJoining :: "entity"
  PreventionOfSingleStrandBreakRepair :: "entity ⇒ bool"
  Repair :: "event ⇒ bool"
  Through :: "event ⇒ entity ⇒ bool"

(* Explanation 1: Loss of BRCA2 causes chromosome breakage. *)
axiomatization where
  explanation_1: "∃x y e. LossOfBRCA2 x ∧ ChromosomeBreakage y ∧ Cause e ∧ Agent e x ∧ Patient e y"

(* Explanation 2: Inhibition of PARP results in collapsed replication forks and double strand breaks, and PARP inhibitors directly cause these double strand breaks. *)
axiomatization where
  explanation_2_1: "∃x y z e1 e2. InhibitionOfPARP x ∧ CollapsedReplicationForks y ∧ DoubleStrandBreaks z ∧ Result e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Patient e1 z"
axiomatization where
  explanation_2_2: "∃x y e. PARPInhibitors x ∧ DoubleStrandBreaks y ∧ Cause e ∧ Agent e x ∧ Patient e y ∧ Directly e"

(* Explanation 3: Loss of BRCA2 drives cancer development via genomic instability. *)
axiomatization where
  explanation_3: "∃x y e. LossOfBRCA2 x ∧ CancerDevelopment y ∧ Drive e ∧ Agent e x ∧ Patient e y ∧ Via e GenomicInstability"

(* Explanation 4: Trapping of PARP1 at sites of double strand breaks increases non-homologous end joining and increases toxicity. *)
axiomatization where
  explanation_4: "∃x y e1 e2. TrappingOfPARP1 x ∧ DoubleStrandBreaks y ∧ Increase e1 ∧ Agent e1 x ∧ Patient e1 NonHomologousEndJoining ∧ Increase e2 ∧ Agent e2 x ∧ Patient e2 Toxicity"

(* Explanation 5: PARP inhibitors prevent single strand break repair, which leads to replication-associated double strand breaks. *)
axiomatization where
  explanation_5: "∃x y e1 e2. PARPInhibitors x ∧ SingleStrandBreakRepair y ∧ Prevent e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Lead e2 ∧ Agent e2 x ∧ Patient e2 ReplicationAssociatedDoubleStrandBreaks"

(* Explanation 6: PARP inhibitors rely on defective homologous recombination repair and error-prone non-homologous end joining to repair DNA. *)
axiomatization where
  explanation_6: "∃x e. PARPInhibitors x ∧ Rely e ∧ Agent e x ∧ On e DefectiveHomologousRecombinationRepair ∧ On e ErrorProneNonHomologousEndJoining"

(* Explanation 7: The prevention of single strand break repair by PARP inhibitors results in replication-associated double strand breaks, which are then repaired through defective homologous recombination repair and error-prone non-homologous end joining. *)
axiomatization where
  explanation_7: "∃x y e1 e2. PreventionOfSingleStrandBreakRepair x ∧ PARPInhibitors y ∧ Result e1 ∧ Agent e1 x ∧ Patient e1 ReplicationAssociatedDoubleStrandBreaks ∧ Repair e2 ∧ Agent e2 y ∧ Through e2 DefectiveHomologousRecombinationRepair ∧ Through e2 ErrorProneNonHomologousEndJoining"

theorem hypothesis:
  assumes asm: "PARPInhibitors x"
  (* Hypothesis: PARP inhibitors cause replication‐associated double strand breaks by preventing single strand break repair, relying on defective homologous recombination repair and error-prone non-homologous end joining to repair DNA *)
  shows "∃x y z e1 e2 e3. PARPInhibitors x ∧ DoubleStrandBreaks y ∧ SingleStrandBreakRepair z ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Prevent e2 ∧ Agent e2 x ∧ Patient e2 z ∧ Rely e3 ∧ Agent e3 x ∧ On e3 DefectiveHomologousRecombinationRepair ∧ On e3 ErrorProneNonHomologousEndJoining"
proof -
  (* From the premise, we have the known information about PARP inhibitors. *)
  from asm have "PARPInhibitors x" by simp
  (* There is a logical relation Implies(F, E), Implies(PARP inhibitors, Double strand breaks) *)
  (* From explanation 2_2, we know that PARP inhibitors cause double strand breaks. *)
  then have "DoubleStrandBreaks y" sledgehammer
  (* From explanation 5, PARP inhibitors prevent single strand break repair, which leads to replication-associated double strand breaks. *)
  (* This implies that there exists an event where PARP inhibitors prevent single strand break repair. *)
  from explanation_5 have "∃z e2. SingleStrandBreakRepair z ∧ Prevent e2 ∧ Agent e2 x ∧ Patient e2 z" <ATP>
  (* From explanation 6, PARP inhibitors rely on defective homologous recombination repair and error-prone non-homologous end joining to repair DNA. *)
  (* This implies that there exists an event where PARP inhibitors rely on these repair mechanisms. *)
  from explanation_6 have "∃e3. Rely e3 ∧ Agent e3 x ∧ On e3 DefectiveHomologousRecombinationRepair ∧ On e3 ErrorProneNonHomologousEndJoining" <ATP>
  (* Combining these, we can construct the required existential statement. *)
  then show ?thesis <ATP>
qed

end
